Fuda Cancer Hospital
Leukemia chemotherapy in China typically costs from $16,500 to $38,000. The final price depends on the hospital type, drug selection, and treatment phase. In the US, similar procedures cost around $35,000 on average. Patients save around 53% compared to US prices. Standard international packages often include diagnostics, initial chemotherapy cycles, and hospital stays.
Bookimed Expert Insight: China offers high-value options for complex blood diseases at JCI-accredited facilities. Fuda Cancer Hospital in Guangzhou is world-renowned for late-stage cancer treatment. Lu Daopei Hematology Hospital in Beijing provides specialized care for refractory leukemia. Beijing Kyoto Children's Hospital focuses on high-risk pediatric cases. Choosing these specialized hubs ensures access to experienced hematologists and advanced protocols.
| China | Turkey | Austria | |
| Leukemia chemotherapy | from $16,500 | from $8,000 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Leukemia chemotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Leukemia chemotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Leukemia chemotherapy journey.
Day 1
Day 2
Day 3
Day 4 - Day 10 (Treatment Days)
Day 11 - Day 14 (Post-Treatment)
Week 2 - Week 4 (Rehabilitation)
Please note that each patient"s recovery timeline may vary based on individual circumstances and the severity of the disease.
Dr. Li Ping, M.D., Ph.D., is Chief Physician and Professor in the Department of Hematology at Shanghai Tongji Hospital, Tongji University School of Medicine. She supervises doctoral and master's students and is an expert in hematologic malignancies.
She earned a Doctor of Medical Science from Nagoya University and completed postdoctoral research. She specializes in diagnosing and treating blood cancers. Her focus includes lymphoid malignancies—leukemias, lymphomas, and multiple myeloma. She treats patients with chemotherapy, hematopoietic stem cell transplantation, targeted therapy, and immunotherapy.
She is a pioneer in China in full-cycle CAR-T therapy for relapsed or refractory blood cancers. She leads and participates in national and international clinical trials. She serves on committees of professional societies, including the China Anti-Cancer Association. She also publishes and trains hematologists.
Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.